Pharmaceuticals & Biotechnology

10 companies in the SciRisk 100. Median Risk Capital Intensity 0.202% — 2.7x the index median.

Companies

Aggregate ESCRC

$1.29bn

Average ESCRC

$128.9m

Median ESCRC

$117.5m

Median intensity

0.202%

Sector revenue

$556bn

Aggregate ESCRC is the sum of independently-calculated company-level ESCRC estimates. It should not be interpreted as unique system-wide (or sector-wide) supply-chain risk capital: company supply-chain exposures overlap — many suppliers in this dataset appear in more than one company's network — and the model does not net out or de-duplicate that overlap when figures are summed.

ESCRC is the 95% one-year Value-at-Risk of supply-chain disruption loss, from SciRisk ESCRC Model v5.5.1. Bars are scaled to the index maximum. Change is ESCRC versus the 2026.09-22 publication (2026-09-19); a dash means the company is new to the index since then.
Rank	Company	Ticker	Country	Sector	RevenueUSD bn	ESCRCUSD m	ESCRC / Revenue%	Risk Grade	Change
6	Pfizer	PFE	USA	Pharmaceuticals & Biotechnology	58.0	284.9	0.491	SC5 Very High	0.0%
15	Johnson & Johnson	JNJ	USA	Pharmaceuticals & Biotechnology	88.0	172.7	0.196	SC4 High	0.0%
17	Roche	ROG.SW	Switzerland	Pharmaceuticals & Biotechnology	66.0	137.1	0.208	SC4 High	0.0%
22	AstraZeneca	AZN	United Kingdom	Pharmaceuticals & Biotechnology	54.0	118.9	0.220	SC5 Very High	0.0%
23	Merck & Co.	MRK	USA	Pharmaceuticals & Biotechnology	64.0	118.6	0.185	SC4 High	0.0%
25	Eli Lilly	LLY	USA	Pharmaceuticals & Biotechnology	45.0	116.3	0.259	SC5 Very High	0.0%
26	Novartis	NVS	Switzerland	Pharmaceuticals & Biotechnology	45.0	116.3	0.258	SC5 Very High	0.0%
35	Sanofi	SNY	France	Pharmaceuticals & Biotechnology	47.0	85.9	0.183	SC4 High	0.0%
40	GSK	GSK	United Kingdom	Pharmaceuticals & Biotechnology	39.0	71.2	0.183	SC4 High	0.0%
42	Bayer	BAYN.DE	Germany	Pharmaceuticals & Biotechnology	50.0	66.9	0.134	SC4 High	0.0%

Risk Capital Intensity

Ranked by intensity rather than by ESCRC — a different ordering from the table above, which is the point of tracking both.

0.491%

0.259%

0.258%

0.220%

0.208%

0.196%

0.185%

0.183%

0.183%

0.134%

How does your supply chain compare with Pharmaceuticals & Biotechnology?

The median company in this sector carries risk capital worth 0.202% of revenue, 2.7 times the index median. Run your own network on the same engine and see which side of that you land on.

Calculate your ESCRC All sectors

ESCRC calculated using SciRisk ESCRC Model v5.5.1 · calibrated priors 2026.09-6
Company data as of 2026-06-30 · ESCRC calculated 2026-09-22 · dataset 2026.09-23 Beta

Simulation: 100,000 Monte Carlo paths · 95% confidence · 365-day horizon
Seed: 20260821 · regional correlation ρ = 0.35

SciRisk ESCRC is an analytical estimate generated using the SciRisk Economic Supply Chain Risk Capital methodology. It is not a credit rating, investment recommendation or statement of financial condition. Figures are model-implied and intended for screening and comparison, not as calibrated capital requirements.

Beta / preliminary dataset. Company inputs are analyst-curated from public annual reports and public supply-chain disclosure. ESCRC itself is computed by the production ESCRC engine — only the INPUTS on this page are preliminary.